Screener
Sabra Healthcare SBRA Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestments.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Real estate investments, net of accumulated depreciation of $1,257,489 and $1,224,663 as of March 31, 2026 and December 31, 2025, respectively | $4,702,791 | $4,686,377 |
| Loans receivable and other investments, net | 432,909 | 434,100 |
| Investment in unconsolidated joint ventures | 116,537 | 118,166 |
| Cash and cash equivalents | 116,530 | 71,537 |
| Restricted cash | 6,921 | 6,603 |
| Lease intangible assets, net | 67,414 | 65,321 |
| Accounts receivable, prepaid expenses and other assets, net | 148,088 | 111,292 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's equity method investments?
- Sabra Healthcare (SBRA) reported equity method investments of $116.54M in Q1 2026.
- How has Sabra Healthcare's equity method investments changed year-over-year?
- Sabra Healthcare's equity method investments decreased by 3.6% year-over-year, from $120.84M to $116.54M.
- What is the long-term trend for Sabra Healthcare's equity method investments?
- Over 5 years (2020 to 2025), Sabra Healthcare's equity method investments has grown at a -16.4% compound annual growth rate (CAGR), from $288.76M to $118.17M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Sabra Healthcare's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude